Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$28,500.00

Lipid adaptations of mycobacterium tuberculosis

FY 2010-11

Summary
Tuberculosis (TB) in humans is an extremely complex infection that is caused by the bacilli Mycobacterium tuberculosis. Despite more than half a century of effective chemotherapy, 100 million new TB infections still occur each year. In 2004, approximately 1.7 million people died worldwide as a result of this devastating disease. Clearly, this ongoing situation warrants new approaches to improve our current level of understanding of the mechanisms underpinning the bacterial-host relationship. To date, the majority of bacterial factors that are associated with virulence and pathogenesis of M. tuberculosis include various classes of waxes and glycolipids present in the lipid-rich bacterial cell wall. In addition, it has become increasingly apparent over recent years that M. tuberculosis lipids contribute to the development of strain diversity amongst circulating TB isolates. As such, the hypothesis of the proposed research program is that variable expression of lipids and lipid-modification strategies represents a major mechanism for the generation of pathogenic diversity in M. tuberculosis. An integral part of this program is also the demonstration of the mechanistic basis for the inflammatory processes that result from the interaction between host macrophages and differentially expressed M. tuberculosis lipids. This program provides an invaluable opportunity to start to define the range of strategies by which M. tuberculosis strains have independently evolved to adapt to and exploit the hostile macrophage environment within the host. It also provides a unique set of tools with which to expand our current knowledge of signaling pathways associated with innate immunity and inflammation, as well as ways to perturb these important pathways. The results of these studies will be directly applicable to understanding many critical aspects of host-pathogen biology and to the cell sciences in general.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
342048-2007
Name nom
Reed, Michael
Department département
Medicine, Faculty of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2007
Award amount
28500
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
4
Nb partie
5
Application title
Lipid adaptations of mycobacterium tuberculosis
Keyword
NSERC
Application summary
Tuberculosis (TB) in humans is an extremely complex infection that is caused by the bacilli Mycobacterium tuberculosis. Despite more than half a century of effective chemotherapy, 100 million new TB infections still occur each year. In 2004, approximately 1.7 million people died worldwide as a result of this devastating disease. Clearly, this ongoing situation warrants new approaches to improve our current level of understanding of the mechanisms underpinning the bacterial-host relationship. To date, the majority of bacterial factors that are associated with virulence and pathogenesis of M. tuberculosis include various classes of waxes and glycolipids present in the lipid-rich bacterial cell wall. In addition, it has become increasingly apparent over recent years that M. tuberculosis lipids contribute to the development of strain diversity amongst circulating TB isolates. As such, the hypothesis of the proposed research program is that variable expression of lipids and lipid-modification strategies represents a major mechanism for the generation of pathogenic diversity in M. tuberculosis. An integral part of this program is also the demonstration of the mechanistic basis for the inflammatory processes that result from the interaction between host macrophages and differentially expressed M. tuberculosis lipids. This program provides an invaluable opportunity to start to define the range of strategies by which M. tuberculosis strains have independently evolved to adapt to and exploit the hostile macrophage environment within the host. It also provides a unique set of tools with which to expand our current knowledge of signaling pathways associated with innate immunity and inflammation, as well as ways to perturb these important pathways. The results of these studies will be directly applicable to understanding many critical aspects of host-pathogen biology and to the cell sciences in general.